Dr Reddy’s runs into trouble with its weight-loss drug – Financial Times

Dr Reddy’s runs into trouble with its weight-loss drug  Financial TimesIndia’s Dr Reddy’s says semaglutide shipping disruption to last until at least late October  ReutersQuality concerns hit cheap Ozempic copies in India within months of blockbuster launch  India TodayDr Reddy’s faces semaglutide setback, but Nomura keeps ‘Buy’; here’s why it sees Rs 1,740 target  Moneycontrol.comRecalls by Dr Reddy’s, Torrent Put Spotlight on Quality Standards in India’s Semaglutide Market  Medical Dialogues